SARS-CoV2 infection as a potential trigger for severe relapse in a patient with multiple sclerosis who stopped disease modifying treatment due to COVID-19 pandemic

BACKGROUND: During COVID-19 pandemic safety of disease modifying treatments (DMT) in patients with multiple sclerosis (MS) is still under debate. While there is no clear evidence for a higher risk of severe SARS-CoV-2 infection under DMT the risk of rebound of disease activity in case of stopping DM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuroimmunology Reports
Main Authors: Auer, Michael, Berek, Klaus, Fava, Elena, Zinganell, Anne, Deisenhammer, Florian, Hegen, Harald, Di Pauli, Franziska
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285927/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nerep.2021.100005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados